Blood transfusion rate in patients undergoing prostate surgery

Background: Benign prostatic hyperplasia is defined as enlargement of the prostate gland in the presence of symptoms of urinary without evidence of malignancy. For patients who have failed medical management as first line of therapy, surgical intervention will be done as the treatment. Hemorrhage is one of the most dreadful and serious complications of Prostate surgery. Bleeding can often be significant and lead to increased morbidity and occasionally mortality. If it persists, it may necessitate blood transfusion and can lead to clot retention in the postoperative period. Method: In this study, 87 patients with Benign prostatic hyperplasia who underwent surgical intervention (open prostatectomy and Transurethral resection of prostate) for one year have been studied. The percentage of Packed Cell which was transfused was determined and Compared based on other variables. Data were collected, and analyzed by SPSS. Results: The average age of the patients was 71/3±9/56. 26.4% were under 65 years old, 93.1% underwent Transurethral resection of prostate surgery, 7.7% blood transfusion. 12.6% had diabetes, 41.4% high blood pressure, 10.3% ischemic heart disease, 1.1% dyslipidemia and 3.4% had hypothyroidism. Preoperative hemoglobin was 13.16 ± 1.83 and postoperative hemoglobin was 12.33 ± 2.17, preoperative hematocrit was 38.64 ± 4.84, and postoperative hematocrit was 36.72± 5.72. Conclusion: Transurethral resection of prostate surgery had the lower rate of blood transfusion compared to open surgery. Patients' age and history of underlying diseases were not significantly related to blood transfusion percentage in these patients. However, the frequency of blood transfusion was higher in patients with hypertension than in other diseases.